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Thirty-two patients died of pancreatitis and its com-
plications over a 10-year period. Infection (bacteremia,
fungemia, or pancreatic ahscess) was the major cause
of death in 80%. In the remaining 20%, refractory
hypotension or respiratory failure were the lethal mech-
anisms. In only 78% of patients was the correct diag-
nosis made hefore death. Ninety-four percent of those
who died did so during their first clinical episode of
pancreatitis. Prophylactic antibiotics did not prevent
the development of pancreatic abscesses and organisms
resistant to the antibiotics used often became the pri-
mary pathogens. Certain prognostic factors reliably sep-
arated those who died from those who lived. Peritoneal
lavage and dialysis may be helpful in both the early
diagnosis and therapy of severe acute pancreatitis.
INTRODUCTION
"Acute pancreatitis is the most terrible of all the
calamities that occur in connection with the abdominal
viscera. The suddenness of its onset, the illimitable
agony which accompanies it, and the mortality attend-
ant upon it all render it the most formidable of catas-
trophes" (1).
Acute pancreatitis describes a clinical spectrum rang-
ing from mild, self-limited symptoms of epigastric pain,
nausea, and vomiting to an overwhelming, rapidly fatal
illness. Biliary tract disease and alcoholism remain the
most commonly recognized etiologies (2-4). Biliary
tract disease has a mortality of 10-15% while alcoholic
pancreatitis has a 1-5% mortality rate (2-6). Mortality
is highest (20-40%) in cases occurring postoperatively
and in those in which there is no apparent etiology.
Overall, a given episode of pancreatitis has an approx-
imate 5-15% mortality, a figure which has remained
constant in most reviews over the last 20 years (7-10).
This study was undertaken to examine the clinical
course of patients dying with acute pancreatitis. Data
were analyzed to assess the modes of presentation, the
role of concurrent disease in affecting survival, the
actual mechanisms leading to death, the use of anti-
biotics and their relation to the infectious complications
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of pancreatitis and whether certain prognostic factors
were useful in predicting the outcome ofthe disease.
METHODS AND PATIENTS
The hospital records of patients who died with acute
pancreatitis were reviewed. Patients were included for
evaluation when pancreatitis was the predominant
cause of death and when a diagnosis of either diffuse
hemorrhagic or necrotizing pancreatitis was made at
either surgery or autopsy. Patients were excluded when
pancreatitis was not a significant finding at surgery or
autopsy. From 1969-1979 there were 32 patients at the
University of Michigan Hospitals in whom pancreatitis
was the predominant cause of death. Over the same 10-
year period, 410 patients had a primary or secondary
discharge diagnosis of acute pancreatitis for a mortality
rate of 7.8%. An age, sex, and hospital service (medical
or surgical)-matched set of 32 patients who had an
episode of acute pancreatitis and lived was also studied.
RESULTS
In the group of patients who lived, there were 18 men
and 14 women with a mean age of 39 years (range 17-
76). The average length of hospitalization was 9 days.
Of those who died, there were 18 men and 14 women
with a mean age of 49 (range 18-89). The diagnosis of
pancreatitis was confirmed at autopsy in 75% and at
celiotomy in 25%. Diagnosis was made before death in
78% and at autopsy in the remaining 22%. The average
length of hospitalization before death was 51 days. In
both groups approximately two-thirds of the patients
were on a surgical service and one-third on a medical
service. The etiological groups are shown in Table 1.
Serum amyiase was measured in 90% ofthe patients
who died. In 20% of these it was normal when first
drawn. In both groups of patients the height of the
initial amyiase was >1000 IU/1 in 16 (Table 1). Seven
of these instances were in patients with biliary tract
disease while only two were in alcoholics. Although the
height of the initial amyiase may correlate with the
presence of cholelithiasis (11), it has never been shown
to correlate with prognosis (4, 12, 13).
None ofthe patients who lived but one-third of those




























































* Miscellaneous causes included severe burns, gunshot wounds,
polyarteritis nodosa, systemic lupus erythematosus, hypertriglyceri-
demia, use of L-asparaginase, and cold water drowning.
10 patients were also severely hypotensive. The pres-
ence of either an elevated serum amyiase or peritoneal
signs (rigid abdomen or absent bowel sounds) was
helpful in localizing pathology to the abdomen in nine.
In the entire series, of the seven patients who did not
have the diagnosis made before death, three were un-
conscious on admission. In one of them an amyiase
was not measured; in one it was normal; and in one it
was elevated and apparently ignored.
Death occurred in the settings of infection, respira-
tory failure, or renal failure. Infection played a domi-
nant role in the death of 26 (82%) ofthe 32 patients.
Fifteen of these had pancreatic abscesses (diagnosed an
average of 18 days after presentation) and the remainder
developed either overwhelming bacteremia or funge-
mia. Subphrenic abscesses were seen in five patients,
three of whom also had pancreatic abscesses. Most
patients with pancreatic abscesses were also bacteremic
with an organism ultimately found in their abscess.
Culture results were available for 10 of these patients
(Table 2). All but one of these abscesses were polymi-
crobial. Anaerobes were isolated in only one patient
but few anaerobic cultures were obtained. In patients
with cholelithiasis and postoperative pancreatitis who
died, infection was universally present. Twelve of these
14 patients had pancreatic abscesses and the remaining
two had bacteremia. Infection was the cause of death
in half of the alcoholic patients and in 75% of patients
with miscellaneous or idiopathic causes for their pan-
creatitis. Only one infectious complication was seen in
the patients who lived (a pancreatic abscess developing
after cholecystectomy which was drained without com-
plication).
Antibiotics were used in 30/32 (94%) ofthe patients
who died and in 6/21 (29%) of those who lived. They
were used in a "prophylactic" sense (empiric therapy
on admission without documentation of infection) in
more than one-half of the patients in both groups who
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* The abscesses were polymicrobial in nine patients.
were given antibiotics. Virtually every antibiotic on the
market during the years of the study was used. The
most commonly used antibiotics were ampicillin or
cephalothin, usually in combination with gentamicin.
In the group who died receiving antibiotics empirically,
all but one still died of an infectious complication and
all of these were with organisms resistant to the original
antibiotic choice. Superinfection with Candida albicans
occurred commonly during antibiotic therapy, being
seen as part ofthe abscess flora in three patients and in
the blood of six. In the patients who lived, no fungal
superinfection occurred.
An adult respiratory distress syndrome-like picture
was seen in almost 20% ofthe total group. It occurred
in patients among all subgroups. The mean time of
onset of this complication was 3 days after symptoms
began and no cases appeared after 7 days. Arterial
hypoxemia (pO2 <60mm Hg) was present in 50% of all
patients who died within the 1st wk of their illness. The
six patients who died of adult respiratory distress syn-
drome all had either acute renal failure or a pancreatic
abscess; in fact, half of these six had all three conditions.
Thus the lethal respiratory failure seen in this series
occurred only with another major complication of pan-
creatitis.
Renal failure was coexistent with the onset of pan-
creatitis in four patients and developed in nine of the
patients who died. In the group with pre-existing renal
failure, one each also had accompanying biliary tract
disease, alcoholism, or SLE. The remaining patient had
chronic pyelonephritis. Hypotension as an etiology for
the renal failure could be clearly demonstrated in six of
these nine patients.
Several sets of criteria exist which attempt to predict
the clinical outcome (survival or death) of an attack of
acute pancreatitis based on an assessment of certain
factors early in the course of the disease. Perhaps the
best studied are those of Ranson and colleagues (4, 12-
14) who evaluated 43 objective findings during the first
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48 h of pancreatitis and found 11 predictive of "serious"
pancreatitis; i.e., leading to death or requiring >7 days
in an intensive care unit (Table 3). In 350 patients with
<3 prognostic signs, the mortality was 0.9%. In 100
patients with >3 prognostic signs, mortality increased
from 16% in those with three or four signs to 100% in
those with seven or eight signs (14). Factors shown to
be not predictive of serious illness or mortality were
any findings on physical exam or the presence and
height of the serum amyiase. In this series the mean
number of prognostic factors present in those who died
was 6.1 (range of 3-9) and in the group who lived a
mean of 0.3 (range 0-2; p < 0.001 by x^). Twenty of
the patients who lived had none of these signs present.
In the group who died the most common signs were
leukocytosis, hypocalcemia, hypoxemia, and decreased
renal function.
Therapeutic peritoneal dialysis was attempted in five
of the patients who died. In three patients dialysis was
administered for renal failure late in their clinical
course. Two patients received dialysis as therapy for
pancreatitis: one received it 7 days after onset and died
24 h later, and another died shortly after one cycle of
dialysis had been given.
DISCUSSION
Previous studies of lethal pancreatitis, comprising
435 cases studied with autopsy since the detailed path-
ologic study of Fitz in 1889 (15), have underscored
several facts observed in this study. The vast majority
of patients who die of acute pancreatitis do so during
their first clinical episode ofthe disease. Of 315 patients
in the literature for which these data are obtainable
(including the current series of 32), 17 (6%) had had a





Glucose >200 mg/100 ml
White blood cells >16,000/mm'
Lactose dehydrogenase >35O IU/1
SGOT >250 Sigma-Frankel U/100 ml
Within 48 h
Decreased hematocrit by >10%
Calcium <8 mg/100 ml
Base deficit >4 mEg/1
Blood urea nitrogen increase by >5 mg/
100 ml
Fluid sequestration >6 1
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half of the deaths occur in the first few days, usually of
hypovolemia or respiratory complications. Those who
survive for 1 wk often succumb later to infectious
sequelae. From 10-50% of cases are diagnosed on the
autopsy table and almost all of these are patients who
die within 24-48 h after admission (15-18). These are
also the patients most likely to be comatose and have
the diagnosis missed (19).
Infection is the overwhelming cause of death in pa-
tients surviving beyond 1 wk. A pancreatic abscess is
seen in 4-9% of patients with acute pancreatitis with a
mortality rate of 25-57%, despite advances in diagnosis,
aggressive surgical management, and antibiotic therapy
(20-23). Possible routes of infection include invasion
from infected bile, direct penetration through the wall
ofthe transverse colon, and hematogenous or lymphatic
spread (2). In approximately half, the abscesses are
polymicrobial although in this study 10/11 (91%) had
multiple organisms. Most series were compiled before
the advent of current anaerobic technology but one
report found Bacteroides spp. in 15% of cases (22).
Enterobacteriaceae predominate with Eseherichia coli
and Klebsiella seen most frequently. C. albicans is seen
only in well-established abscesses and probably repre-
sents superinfection due to prior antibiotic therapy.
The controversy over the use of prophylactic anti-
biotics during acute severe pancreatitis has not been
settled. One retrospective (24) and three prospective
studies comprising over 700 patients have compared
outcome in patients given prophylactic ampicillin (25,
26) or cephalothin (24, 27) and found no difference in
morbidity or mortality. However, virtually all of the
patients in these studies were alcoholics with mild pan-
creatitis, a group expected to have the lowest mortality.
Should a pancreatic abscess develop, mortality is
highest (80-85%) in those patients with biliary tract
disease or postoperative etiologies (6). Most patients in
these groups, however, are already receiving antibiotics.
Indeed, in the patients who died, half were already
receiving antibiotics at the time that an ultimately fatal
infectious complication developed. Organisms (bacte-
rial or fungal) that were subsequently recovered from
the blood or abscesses in these patients were uniformly
resistant to the antibiotics initially used. The subgroup
with biliary tract disease may be one in which prophy-
lactic antibiotics would deserve a trial, since their mor-
tality is so high if infection does occur. At present,
however, there is no good data to support the use of
prophylactic antibiotics in acute pancreatitis, especially
in patients who are not critically ill on presentation.
The adult respiratory distress syndrome occurred in
20% of those dying. All six of these patients died, which
is a higher mortality from this process than that previ-
ously reported (28). However, a similarly high mortality
from respiratory failure in alcoholics with acute pan-
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creatitis has been observed (16, 27). These six patients
all had at least one other major metabolic process, such
as renal failure or infection, which may have directly
contributed to this higher mortality.
Pancreatitis has been reported to occur at a higher
rate in patients with pre-existing renal failure (3). In
this series, however, three of four such patients had
another associated condition such as alcoholism. Oli-
guric renal failure is not uncommon in acute pancrea-
titis, especially in the first 24-48 h after presentation.
Hypovolemia as a cause of renal failure could account
for six of nine such instances in this study. However,
in three of these nine and in at least 18 other patients
described in the literature (29, 30), hypotension could
not be documented (although perhaps not detected)
and some other factor, such as a circulating vasopressor
having selective renal activity, has been postulated to
cause acute renal failure (2, 31).
Several attempts have been made to predict the clin-
ical severity of a given episode of acute pancreatitis.
The studies of Ranson and colleagues (4, 12-14) did
not fmd predictive utility from any parameters on
physical exam, while others have (32). This study also
illustrated the use of Ranson's criteria in predicting a
high risk group of patients with those living having a
mean of 0.5 prognostic factors while those dying had
6.1.
There has been recent interest in the role of peritoneal
lavage and dialysis in both the diagnosis and therapy of
acute pancreatitis early in its course. Diagnostic peri-
toneal lavage (considered positive if more than 10 ml
of free peritoneal fluid was obtained or any lavage
return with a dark color) was found as predictive ofthe
subsequent clinical course as a clinical grading scheme
or the criteria of McMahon et al. (33). A randomized
trial of therapeutic peritoneal lavage in 70 patients
thought to have severe alcoholic pancreatitis (hypocal-
cemia, acidosis, hypotension, hypoxemia) found "im-
provement" at 24 h and less mortality in the group
dialyzed (27). An earlier report of Ranson and Spencer
(34) showed a dramatic reduction in the early mortality
of pancreatitis in patients given 48 h of peritoneal
dialysis. However, late mortality (almost all due to
pancreatic abscesses) was unaffected. These studies
have thus suggested at least improved early survival in
those patients supported with peritoneal dialysis and it
may deserve a wider role in diagnosis and therapy than
it currently has.
Since virtually all patients who die of acute pancrea-
titis do so during their first clinical episode ofthe disease
(regardless of etiological subgroup), particular attention
to their changing physiology and the appearance of
prognostic factors should be assessed early in the clinical
course. Serum amyiase, although not predictive, is a
useful screening device and may have particular utility
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in unconscious patients, as their pancreatitis is often
diagnosed postmortem (19). The role of prophylactic
antibiotics has not been clarified in severely ill patients,
but if proven beneficial, may offer a means of dimin-
ishing the late mortality from infection (especially in
patients with biliary tract pathology). The role of peri-
toneal lavage and dialysis in the early diagnosis and
therapy of severe pancreatitis deserves further study.
Reprint requests: Dr. Timothy T. Nostrant., Department of Inter-
nal Medicine, D-2105 South Ambulatory Care Building, University
ofMichigan, Ann Arbor, MI 48109.
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